These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9387056)

  • 1. Analysis of the factors influencing the osmolality of eight monomeric nonionic iodinated contrast medium molecules.
    Violon D
    Invest Radiol; 1997 Nov; 32(11):684-9. PubMed ID: 9387056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA; García-Molina M; Gamboa Ó
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscosity of iodinated contrast agents during renal excretion.
    Jost G; Lengsfeld P; Lenhard DC; Pietsch H; Hütter J; Sieber MA
    Eur J Radiol; 2011 Nov; 80(2):373-7. PubMed ID: 21376497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical parameters of x-ray contrast media.
    Krause W; Miklautz H; Kollenkirchen U; Heimann G
    Invest Radiol; 1994 Jan; 29(1):72-80. PubMed ID: 8144342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents.
    Longo DL; Michelotti F; Consolino L; Bardini P; Digilio G; Xiao G; Sun PZ; Aime S
    Invest Radiol; 2016 Mar; 51(3):155-62. PubMed ID: 26460826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
    Lenhard DC; Frisk AL; Lengsfeld P; Pietsch H; Jost G
    Invest Radiol; 2013 Apr; 48(4):175-82. PubMed ID: 23262792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the effectiveness of X-ray contrast media for abdominal computed tomographic examinations: comparison of four low-osmolality agents.
    Martí-Bonmatí L; Ronchera-Oms CL; Espinós MA; Jordán Y; Lucas A
    J Clin Pharm Ther; 1995 Apr; 20(2):75-81. PubMed ID: 7650078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nonionic monomeric and dimeric contrast media on the twitching reaction of the rat. Importance of osmolality and electrolyte content.
    Bååth L; Besjakov J; Pettersson G
    Invest Radiol; 1994 Nov; 29(11):985-9. PubMed ID: 7890513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the lateral/facial protection model to a new molecule, iobitridol.
    Violon D
    Invest Radiol; 1996 Oct; 31(10):668-70. PubMed ID: 8889656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of the hydrophilic sphere of non-ionic monomers: are all protected in a similar way?
    Violon D
    Br J Radiol; 2001 Dec; 74(888):1097-102. PubMed ID: 11777766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
    Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
    Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local effect of three nonionic contrast media on the arterial blood flow velocity during iliofemoral arteriography.
    Zwaan M; Von Helden J; Weiss HD
    Invest Radiol; 1999 Jan; 34(1):5-12. PubMed ID: 9888048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Adverse Reactions to Nonionic Iodinated Contrast Media: A Meta-Analysis.
    Suh YJ; Yoon SH; Hong H; Hahn S; Kang DY; Kang HR; Choi YH; Lee W
    Invest Radiol; 2019 Sep; 54(9):589-599. PubMed ID: 30998567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
    Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
    Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current contrast media and ioxilan. Comparative evaluation of vascular pain by aversion conditioning.
    Sovak M; Halkovich CA; Foster SJ
    Invest Radiol; 1988 Sep; 23 Suppl 1():S84-7. PubMed ID: 3198369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmolality of nonionic contrast media.
    Miklautz H; Fichte K; Wegscheider K
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():16-20. PubMed ID: 2568786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind study of a new nonionic contrast agent for digital subtraction arteriography.
    Weiss JP; McLean GK; Modic MT; Rees CR; Higashida RT
    Invest Radiol; 1994 May; 29 Suppl 1():S84-92. PubMed ID: 8071051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan.
    Misumi K; Tateno O; Fujiki M; Miura N; Sakamoto H
    J Vet Med Sci; 2000 Apr; 62(4):421-6. PubMed ID: 10823730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.